Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD

Prolidase deficiency (PD) is a rare autosomal recessive inborn error of immunity caused by biallelic homozygous or compound heterozygous loss-of-function mutations in PEPD, the gene that encodes prolidase. PD typically manifests with variable dysmorphic features, chronic cutaneous ulcers, recurrent...

Descripció completa

Dades bibliogràfiques

Autors principals:	Torsten Witte, Georgios Sogkas, Natalia Dubrowinskaja, Faranaz Atschekzei, Theresa Graalmann, Mykola Fedchenko, Abdulwahab Elsayed, Felix C Ringshausen
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2023-10-01
Col·lecció:	RMD Open
Accés en línia:	https://rmdopen.bmj.com/content/9/4/e003507.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!